type 1 diabetes
Conditions
Interventions
Group of glucose-lowering drugs (GLDs) as an adjunct to insulin:None
Insulin group:None
Sponsors
Shanghai General Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1.The research group consists of T1DM patients who first used oral hypoglycemic drugs from January 2013 to June 2024 and had a glycated hemoglobin level of >= 7%; The control group consisted of T1DM patients who maintained only insulin treatment regimen and had glycated hemoglobin >= 7%; 2.Age >= 18 years old; 3.At least one recorded HbA1c value before the start of treatment; 4.Maintain medication regimen as needed from baseline to at least 3 months; 5.Record the first glycated hemoglobin value after treatment.
Exclusion criteria
Exclusion criteria: 1.The patient had already used hypoglycemic drugs as an adjunct to insulin therapy before admission; 2.DKA? Serious infection, perioperative status, severe trauma, pregnancy, patient's past or current involvement in interventional clinical research; 3.The standard for determining stress hyperglycemia by the supervising physician; 4.Patients who have no medication records or have not followed the treatment plan formulated by the doctor.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| HbA1c;Absolute and relative insulin doses; | — |
Countries
China
Contacts
Public ContactShi Chenyang
Shanghai General Hospital
Outcome results
None listed